A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma

被引:0
作者
Schoenfeld, David [1 ]
Djureinovic, Dijana [1 ]
Zhang, Lin [1 ]
Mann, Jacqueline [1 ]
Huck, John [2 ]
Jilaveanu, Lucia [1 ]
Ring, Aaron [2 ]
Kluger, Harriet [1 ]
机构
[1] Yale Sch Med, Sect Med Oncol, New Haven, CT USA
[2] Yale Sch Med, Dept Immunobiol, New Haven, CT USA
关键词
IL-18; cytokines; immune-checkpoint inhibitors; anti-CTLA-4; preclinical models; RCC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
58
引用
收藏
页码:S7 / S7
页数:1
相关论文
empty
未找到相关数据